Author: Site Staff

New Orleans-based Revolo Biotherapeutics Activates Clinical Trial and Commences Enrollment in Phase 2 Clinical Study of ‘1104 in Allergic Disease in the UK

  NEW ORLEANS/LONDON (press release) – New Orleans-based Revolo Biotherapeutics (“Revolo Bio” or the “Company”), a company developing therapies that reset the immune system to achieve superior long-term remission for patients with autoimmune and allergic diseases, announced today that a…

The Idea Village Opens Applications for 2022 Accelerator Cohort

  NEW ORLEANS (press release) - The Idea Village has opened applications for VILLAGEx, their flagship accelerator program for emerging, high-growth, technology-enabled startups. The selective four-month program provides the cohort of founders with the resources and connections needed to rapidly…